Immundiagnostik AG (www.immundiagnostik.com), founded in 1986 by Dr. Franz Paul Armbruster (CEO), is specialized on the development, production, and world-wide distribution of innovative parameters and detection methods for laboratory diagnostics and medical research. The main focus is the development of immunological tools, of HPLC and molecular biology methods, and of new applications for mass spectrometry (LC-MS/MS). Immundiagnostik concentrates on the development and production of laboratory diagnostics for the identification of disease risks, for differential diagnosis, and for therapeutic drug monitoring. The company holds a particularly strong portfolio in markers of oxidative stress/anti-aging, gastroenterology and nutrition, skeletal system, and cardio-reno-vascular system. Immundiagnostik owns more than 35 patents in Europe, the US, Japan, Canada, and Australia, is certified according to DIN EN ISO 13485 and fulfills the requirements of the German Medical Device Regulation and the EU IVD Regulations (98/79 EG).